Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.pan.2021.04.005 http://scihub22266oqcxt.onion/10.1016/j.pan.2021.04.005 33926820!8055495!33926820     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pancreatology 2021 ; 21 (6): 1048-51 Nephropedia Template TP {{tp|p=33926820|t=2021. COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals |pdf=|usr=}}{{33926820}} gab.com Text COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals JO: Pancreatology http://www.kidney.de/pget.php?&tw=1&pmid=33926820 #FOAvip BACKGROUND: COVID-19 pandemic-related disruptions to EUS-based pancreatic cancer surveillance in high-risk individuals remain uncertain. METHODS: Analysis of enrolled participants in the CAPS5 Study, a prospective multicenter study of pancreatic cancer surveillance in high-risk individuals. RESULTS: Amongst 693 enrolled high-risk individuals under active surveillance, 108 (16%) had an EUS scheduled during the COVID-19 pandemic-related shutdown (median length of 78 days) in the spring of 2020, with 97% of these procedures being canceled. Of these canceled surveillance EUSs, 83% were rescheduled in a median of 4.1 months, however 17% were not rescheduled after 6 months follow-up. Prior history of cancer was associated with increased likelihood of rescheduling. To date no pancreatic cancer has been diagnosed among those whose surveillance was delayed. CONCLUSIONS: COVID-19 delayed pancreatic cancer surveillance with no adverse outcomes in efficiently rescheduled individuals. However, 1 in 6 high-risk individuals had not rescheduled surveillance, indicating the need for vigilance to ensure timely surveillance rescheduling. Twit Text FOAVip COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals ????Pancreatology http://www.kidney.de/pget.php?&tw=1&pmid=33926820 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33926820 #FOAvip English Wikipedia <ref>{{Cite pmid|33926820}}</ref> COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals #MMPMID33926820 Katona BW; Mahmud N; Dbouk M; Ahmad N; Chhoda A; Dudley B; Hayat U; Kwon RS; Lee LS; Rustgi AK; Ukaegbu C; Vasquez L; Volk S; Brand RE; Canto MI; Chak A; Farrell JJ; Kastrinos F; Stoffel EM; Syngal S; Goggins M Pancreatology 2021[Apr]; 21 (6): 1048-51 PMID33926820show ga BACKGROUND: COVID-19 pandemic-related disruptions to EUS-based pancreatic cancer surveillance in high-risk individuals remain uncertain. METHODS: Analysis of enrolled participants in the CAPS5 Study, a prospective multicenter study of pancreatic cancer surveillance in high-risk individuals. RESULTS: Amongst 693 enrolled high-risk individuals under active surveillance, 108 (16%) had an EUS scheduled during the COVID-19 pandemic-related shutdown (median length of 78 days) in the spring of 2020, with 97% of these procedures being canceled. Of these canceled surveillance EUSs, 83% were rescheduled in a median of 4.1 months, however 17% were not rescheduled after 6 months follow-up. Prior history of cancer was associated with increased likelihood of rescheduling. To date no pancreatic cancer has been diagnosed among those whose surveillance was delayed. CONCLUSIONS: COVID-19 delayed pancreatic cancer surveillance with no adverse outcomes in efficiently rescheduled individuals. However, 1 in 6 high-risk individuals had not rescheduled surveillance, indicating the need for vigilance to ensure timely surveillance rescheduling. äCOVID-19 related pancreatic cancer surveillance disruptions amongst hi(epmc).pdf DeepDyve Pubget Overpricing